Paralysis in Pairs: Insights From Two Cases of Infant Botulism

Dabritz HA Chung CH Read JS Khouri JM. Global occurrence of infant botulism: 2007–2021. Pediatrics. 2025;155(4):e2024068791.

Antonucci L Locci C Schettini L Clemente MG Antonucci R. Infant botulism: an underestimated threat. Infect Dis (Lond). 2021;53(9):647-660. doi:10.1080/23744235.2021.1919753.

Goldberg B Danino D Levinsky Y , et al. Infant botulism, Israel, 2007-2021. Emerg Infect Dis. 2023;29(2):235-241. doi:10.3201/eid2902.220991.

Rosow LK Strober JB. Infant botulism: review and clinical update. Pediatr Neurol. 2015;52(5):487-492. doi:10.1016/j.pediatrneurol.2015.01.006.

Jin J. What Is botulism? JAMA. 2023;330(1):90. doi:10.1001/jama.2023.8085.

Thim T Krarup NH Grove EL Rohde CV Løfgren B. Initial assessment and treatment with the airway, breathing, circulation, disability, exposure (ABCDE) approach. Int J Gen Med. 2012;5:117-121. doi:10.2147/IJGM.S28478.

Centers for Disease Control Prevention. National botulism surveillance: 2019 case summary. U.S. Department of Health and Human Services. Accessed October 8, 2020. https://www.cdc.gov/botulism/php/national-botulism-surveillance/2019.html.

US Census Bureau (2017). American housing survey: 2017 national results. U.S. Department of Housing and Urban Development. Accessed May 20, 2025. https://www.census.gov/programs-surveys/ahs.html.

Risko W. Infant botulism. Pediatr Rev. 2006;27(1):36-37. doi:10.1542/pir.27-1-36.

Fenicia L Anniballi F. Infant botulism. Ann Ist Super Sanita. 2009;45(2):134-146.

Arnon SS Schechter R Maslanka SE Jewell NP Hatheway CL. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006;354(5):462-471. doi:10.1056/NEJMoa051926.

Arnon SS. Infant botulism. In: Feigin RD Cherry JD Demmler GJ Kaplan SL , eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: WB Saunders; 2004:1758-1766.

Centers for Disease Control Prevention. Clinical guidelines for diagnosis and treatment of botulism, 2021. Centers for Disease Control and Prevention. Accessed May 6, 2021. https://www.cdc.gov/mmwr/volumes/70/rr/rr7002a1.htm.

California Department of Public Health. (n.d.). Infant Botulism Treatment and Prevention Program. Accessed May 20, 2025. https://www.infantbotulism.org/physician/patient.php.

Infant Botulism Treatment Prevention Program (nd). Laboratory Testing for Infant Botulism. Accessed March 30, 2025. https://www.infantbotulism.org/laboratorian/laboratory.php.

Kellner JD Neufeld MS McIntyre L. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006;354(5):462-471. doi:10.1056/NEJMoa051926.

Payne JR Khouri JM Jewell NP Arnon SS. Efficacy of human botulism immune globulin for the treatment of infant botulism: the first 12 years post licensure. J Pediatr. 2018;193:172-177.

Audic F Barnerias C. Spinal muscular atrophy (SMA) type I (Werdnig-Hoffmann disease). Arch Pediatr. 2020;27(7S):7S15-7S17. doi:10.1016/S0929-693X(20)30271-2.

Zafeiriou DI Pitt M de Sousa C. Clinical and neurophysiological characteristics of congenital myasthenic syndromes presenting in early infancy. Brain Dev. 2004;26(1):47-52. doi:10.1016/s0387-7604(03)00096-2.

Wassner AJ. Congenital hypothyroidism. Clin Perinatol. 2018;45(1):1-18. doi:10.1016/j.clp.2017.10.004.

Bellanti R Rinaldi S. Guillain-Barré syndrome: a comprehensive review. Eur J Neurol. 2024;31:e16365. doi:10.1111/ene.16365.

Khouri JM Payne JR Arnon SS. More clinical mimics of infant botulism. J Pediatr. 2018;193:178-182.

Garispe A Cherry S. Infant botulism. J Educ Teach Emerg Med. 2023;8(3):O33-O60. doi:10.21980/J88350.

Office AP. HHS announces transformation to make America healthy again. HHS.gov. Accessed April 3, 2025. https://www.hhs.gov/press-room/hhs-restructuring-doge.html.